NCT00193349View on ClinicalTrials.gov

Gleevec Combined With Camptosar Plus Paraplatin in Previously Untreated Extensive Stage Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Lung Cancer
Interventions
DRUG

Imatinib

DRUG

Irinotecan

DRUG

Carboplatin

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

collaborator

Pharmacia and Upjohn

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER

NCT00193349 - Gleevec Combined With Camptosar Plus Paraplatin in Previously Untreated Extensive Stage Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter